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Summary: A spectrum of quantitative and qualitative methods was adapted to the RA-1000/RA-XT selective
analyser for the purpose of excluding or detecting common types of intoxication in the emergency laboratory
of our primary care Community hospital. Ethanol and salicylates (measured photometrically) and acetami-
nophen (measured immunologically by EMIT tox) were quantitatively analysed in serum. Immunological
group tests (EMIT tox) for barbiturates, benzodiazepines, tricyclic antidepressants and related compounds
were used for qualitative analysis. Well established clinical chemical methods (aspartarte aminotransferase,
alanine aminotransferase, creatine kinase, pseudocholinestef äse, glucose and lactate) were applied to the serum
samples using the same selective analyser. Within and between run precision, accuracy, recovery and detection
ranges (linearity) fulfilled the recommendations of forefield toxicological analysis for all methods.
Ethanol (g/l), measured photometrically with the RA-1000 analyser, agreed with the reference method
(headspace gas-chromatography) with a correlation coefficient > 0.99 (y = 0.06 + 0.98x). Acetaminophen
and salicylates showed correlation coefficients > 0.94 and > 0.99, when compared with manual colorimetric
procedures (acetaminophen (mg/1): y = —3.22 + 0.896x; salicylates (mg/1): y = —2.1 + Ix). Qualitative
group tests for barbiturates, benzodiazepines and tricyclic antidepressants measured with the RA-1000 analyser
were in good agreement with the EMIT single test procedure.
The ranges of the quantitative methods allowed quantification of analytes from therapeutic (non-toxic) to
very high levels in undiluted samples (ethaiiol 0.05 up to 4 g/l; salicylates 32 up to 1200 mg/1 and acetaminophen
1.9 up to 200 mg/1). The low detection limits of the qualitative tests allowed the recognition of compounds
in plasma that were present in low concentrations and/or displayed only minor reactivity with the antibodies
provided by the EMIT tox test kits.
As a consequence, decision limits for all three group tests in serum were lowered to near the detection limit:
Barbiturates: 0.5 mg/1 (calibrated with secobarbital)
Benzodiazepines: 0.05 mg/1 (calibrated with nordiazepam)
Tricyclic antidepressants: 0,07 mg/1 (calibrated with nortriptyline)
For quantitative tests the lower linoäts of qüantiflcation were:
Acetaminophen: 10 mg/1;
Salicylates: 50 mg/1;
Ethanol: 0.15 g/l.
The working reagents were stable for at least 14 days.at 4-8 °C. Calibration curves were stable over the
expiration period of reconstituted original reagents (6-12 weeks), also when working reagents were prepared
in aliquots from stored reconstituted reagents.
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Application of the newly adapted programme to serum samples of nearly two hundred patients showed it to
be suitable for screening patients in which intoxication is suspected or needs to be excluded.
Introduction
Despite the importance of checking for acute intoxi-
cation and chronic drug abuse in newly hospitalized
patients, toxicological analysis is not practised äs
widely in German hospitals (1) äs recommended by
an expert group (2). This is probably due to the effort
required for the application of most of the available
procedures.
Intoxications are usually first detected by qualitative
tests (3) based either on direct examination of urine
or of acidic or basic extracts. Moreover, drug-abun-
dance control programmes are commonly based on
the analysis of urine (4), because most substances can
be detected for a longer period in urine than in serum.
However, the severity of an intoxication can only be
derived from plasma values. Apparently, the proce-
dures based on urine analysis (5) do not adequately
meet the requirements for detection or exclusion of
acute intoxication in the emergency laboratory. Serum
or plasma is the primary sample material of newly
hospitalized patients, and its drug content mirrors the
actual state of intoxication better than that of urine.
An analytical programme for serum or plasma there-
fore seemed more appropriate.
Many substances appear in only low levels in plasma
and urine, following the administration of toxicolog^
ically relevant doses. Furthermore, various immuno-
logical detection Systems used for group-specific
measurements differ widely in their sensitivity to dif-
ferent substances within the one group. To overcome
these problems, extraction, hydrolysis of conjugates
and reduction of decision limits have been suggested
äs appropriate Solutions (6-9). For the present needs
of a toxicological emergency programme only those
procedures which need little additional effort seemed
appropriate.
Our purpose was therefore to develop an automated
toxicological screening programme for serum by com-
bining quantitative and qualitative measurements,
and to considerably reduce the operational time and
the cost by adapting the methodology to a selective
analyser.
The aim was to exclude, differentiate and quantify
* various frequent forms of intoxication. The present
methodology can be adapted to a great number of
other mechanised analysers. Parts of this work have
been presented in a preliminary form (10-12).
Materials and Methode
Plasma or serum samples ' f
Samples were drawn äs soon äs possible after admission of the
patient to the hospital. Blood was collected in 4 ml serum or
plasma Separator tubes (Vacutainef®, Becton Dickinson, Mey-
lan Cedex, France) with lithium heparinate äs änticoägülant.
Analytical procedures
Table l summarizes the parameters for adaptation of qualitative
procedures, table 2 of quantitative procedures to the RA-1ÖOO/
RA-XT selective analyser (Bayer Diagnostik-Technicon,
München, Germany). A Software Version inchiding immunoas-
say test capabilities is recommended.
Barbiturates
Barbiturates were measured by enzyme multiplied immünoas-
say (EMIT), using a test kit (EMIT tox barbiturates) purchased
from Syva, Darmstadt, Germany. Stock reagents were prepared
äs prescribed by the manufacturer. For preparation of working
Solutions, reagent l (group-specific antibpdies, Substrates) and
reagent 2 (enzyme-linked secöbarbital äs tfacer) were düuted
10-fold with the buffer solutiori. Using the RA4000 analyser,
plasma (3.5 ) was mixed with 175 working sohition l, and
30 s later 175 working solution 2 was added. After an ad-
ditional 30 s the kinetics were recprded in a period of 30 s.
Barbiturate calibrators A—C (Abbott Diagnostics, Wiesbaden,
Germany) were used. A ealibration curve was constructed using
these Standards or mixtures thereof containing concentrations
of 0, 0.5, 2.0 and 3.5 mg/1 seeobarbital respectively.
This method was compared with the EMIT single test (Syva,
Darmstadt, Germany)., using the photometer from the same
manufacturer. - - .
Benzodiazepines
The procedure for benzodiazepines was analogous to the
method for barbiturates using a test kit (EMIT tox benzodi-
azepines) from Syva, Darmstadt, Germany.
Benzödiazepine calibrators A—F (Abbott Diagnostics, Wies-
baden, Germany) were used äs Standards. A calibration curve
was constructed using concentrations of 0, 0.05, 0.1, 0.2 and
0.4 mg/1 nordiazepam.
This method was compared with the EMIT single test (Syva,
Darmstadt, Germany).
Tricyclic antidepressants
Tricyclic antidepressants and related compounds were also
measured by adaptation of an EMIT procedure (EMIT tox
TCA, Syva, Darmstadt, Germany) to the RA-1000 analyser.
Tricyclic Antidepressant calibrators A—D (Abbott Diagnostics,
Wiesbaden, Germany) were used äs Standards. A calibration
cufve was constructed using concentrations of 0, 0.07, 0.15 and
0.3 mg/1 nortriptyiine.
This method was compared with the EMIT single test (Syva,
° Darmstadt, Germany).
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Tab. 1. Instrumental settings for qualitative EMIT tests in plasma on the RA-1000 analyser.
Parameter Barbiturates
(group reaction)
Reaction type* 1
Sample volume 7% (3.5 μΐ)
Wavelength 1 (340 nm)
Preincubation time** 60 s
Incubation time 30 s
Reading time 30 s
Reagent 1 volume 35% (175 μΐ)
Reagent 2 volume 35% (175 μΐ)
Unit 7 (mg/1)
Detection limit*** 5.0
Normal r nge**** + 0.5
1.0. limit 0.05
Immunoassay type 0
Calibrator 1 0
Calibrator 2 0.5
Calibrator 3 2.0
Calibrator 4 3.5
Calibrator 5 —
LIM 1 to LIM 4 (5) 10
SLM 1 to SLM 4 (5) 99
10/50/90 PAW 99.00
%10/%50/%100 PAW 99
SFQ LIMIT 10
* 1 = 2 point kinetics
** General setting for a reagent tray
*** not equivalent to diluting limit
**** equivalent to the decision limit
LIM = maximal allowable CV (%) for replicate
SLM = normalized deviation = (fitted value —
PAW = predicted concentration when the assay
then applied to the Standard curve
Benzodiazepines
1
7% (3.5 μΐ)
1 (340 nm)
60s
30s
30s
35% (175 μΐ)
35% (175 μΐ)
7 (mg/1)
0.6
0.05
0.05
0
0
0.05
0.1
0.2
0.4
10
99
99.00
99
10
aspirations of corresponding Standard
Tricyclic
antidepressants
1
7% (3.5 μΐ)
1 (340 nm)
60s
30s
30s
35% (175 μΐ)
35% (175 μΐ)
7 (mg/1)
0.5
0.07
0.05
0
0
0.07
0.15
0.3
—10
99
99.00
99
10
expected value) value for maximal Standard concentration
value for a Standard is multiplied by the
%PAW = maximal allowable deviation (in) from the predicted value specified by the PAW
indicated percentage, and
parameter
SFQ = limit on residual sum of squares of fitted calibration curve
Tab. 2. Instrumental settings for quantitative determination of the plasma analytes on the RA-1000 analyser.
Parameter Acetamiriophen Salicylates Ethanol
Reaction type*
Sample volume
Wavelength
Preincubation time**
Incubation time
Reading time
Reagent 1 volume
Reagent 2 volume
Unit
Detection limit
Cal. Factor
Normal r nge +***
Reagent blank
1.0. limit
Endpoint lim.
Immunoassay type
Calibrator 1
Calibrator 2
Calibrator 3
Calibrator 4
Calibrator 5
Calibrator 6
LIM 1 to LIM 6
SLM 1 to SLM 6
10/50/90 PAW
%10/%50/%90 PAW
SFQ LIM
1
7% (3.5 μ!)
1 (340 nm)
60s
30s
30s
35% (175 μΐ)
35% (175 μΐ)
7 (mg/1)
200 mg/1
—
10 mg/1
—1.0
—
*0
0 mg/1
10 mg/1
25 mg/1
50 mg/1
100 mg/1
200 mg/1
10
99
99.099
10
2
60% (30 μΐ)
5 (550 nm)
60s
300s
—
67% (335 μΐ)
7% (35 μΐ)
7 (mg/1)
1200 mg/1
xxxx
50 mg/1
0.0
—
0.02
—
250 mg/1
—
—
—
—
—
—
—
—
—
"
2
4% (2 μΐ)
1 (340 nm)
—
300s
—
75% (375 μΐ)
—
(g/D
4 g/l
1.99
0.15 g/l
0.0
—
0.05
—
—
—
—
—
—
—
—
—
—
—
l = 2 point kinetics; 2 = endpoint ** General setting for a reagent tray *** equivalent to the decision limit
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Aceianrinoplwn
The EMIT proccdure (EMIT tox Acelaminophen, Syva,
Darmsladt) was adaptcd lo the RA-1000 analyser using work-
ing rcagents preparcd äs for the qualitative melhods above.
For prcparation of the Standard curve, calibrators provided
with the test kit vverc used. The calibration curve was con-
structed using concenlrations of 0,10, 25, 50,100 and 200 mg/1.
This method was compared with a manual colorimetric method
aftcr enzymatic hydrolysis (13) using a test kit purchased from
Cambridge Life Sciences, London, UK.
Statistical evaluation
Linear regression analysis was performed using the least square
analysis method (l 5). In addition, the general regression pro-
cedure described by Bablok et al. was applied using the Com-
puter program provided by these authors (16).
The analytical sensitivity of the qualitative immunologieal
screening tests was evaluated by tliie method introduced by
Kutter (17). The decision limit of the qualitative tests was
extended äs described in I.e. (8, 18, 19).
Test results for qualitative methods were compared by testing
for discordancies with the four-fleld-technique.
Salicylates
A colorimetric procedure using a test kit from Sigma, Deisen-
hofen, Germany was adapted to the RA-1000 selective analyser.
The blank reagent provided was used äs working solution 1.
Working solution 2 was prepared by mixing 7.6 parts blank
reagent and one part colour reagent, and this mixture was
stable at 4 °C for at least 4 weeks. As can be seen from table
2, 30 plasma were mixed with 335 working solution l and
60 seconds later 35 working solution 2 was added. After
300 s the final reading at 550 nm was taken. A Standard solution
of 250 mg/1 salicylate provided with the test kit was used for
calibration. A sample blank using working reagent l alone was
measured in parallel.
This method was compared with the manual method using the
same test kit from Sigma.
Elhanol
The alcohol dehydrogenase (EC 1.1.1.1) method was adapted
to the RA-1000 analyser. Reagents, i. e. NAD/ADH-suspension
and glycine buffer containing a non-specified aldehyde captor,
were purchased from Sigma (Deisenhofen, Gennany). Working
reagent was prepared äs prescribed by the manufacturer, and
it was stable for at least 48 hours below 15 °C. Plasma (2 )
was mixed with 375 reagent and a final reading at 340 nm
was taken 300 s thereafter. The concentration of ethanol was
calculated, using the molar absorbance coefficient of NADH
at 340 nm and the factor of 1.992. The method was compared
with the headspace gas chromatography procedure according
tol.c. (14).
Control materials
The intra-assay and inter-assay precision for the analysis of all
analytes except ethanol were determined with a mixture of
Lyphochek TDM Level-1 (Biorad, Munich, Gennany) and
Control Benzodiazepine Serum Level-M (Abbott Diagnostics,
Wiesbaden, Germany). The mixture was prepared by dissolving
the Lyphochek control in the fluid benzodiazepine control (2.5
ml), followed by the addition of 2.5 ml distilled water. Samples
from patients were also used for assessing precision data.
To determine the precision and accuracy of the ethanol method,
different charges of Fluinorm Ethanol R Level I and II (Beh-
ringwerke, Marburg, Germany) were used. The accuracy of the
acetaminophen assay was measured with Lyphochek TDM
Level-3 (Biorad, Munich, Germany) and Control Acetamino-
phen (Syva, Darmstadt, Germany). Lyphochek TDM Level 2/3
were used to determine the accuracy of the salicylate assay. The
calibration curves of the qualitative determinations were
checked with Barbiturates Control L, Benzodiazepines Control
L and Tricyclic Antidepressants Control M (all from Abbott,
Wiesbaden, Germany), and additionally with EMIT st Serum
Calibrator and EMIT st tricyclic antidepressants Calibrator
(Syva, Darmstadt, Germany).
Results
Adaptation of methods
The aim of the present study was to take a combi-
nation of quantitative and qualitative methods for
recognizing acüte intoxication with frequently abused
drugs, and to adapt them to an analyser, which is
used röütinely in the clinical chemistry emergency
laboratory. Using the settings sümmarized in table l
and table 2 this was realised on the RA-1000/RAXT
analyser. The total programme can be performed in
10 minutes using heparin plasma or serum samples.
In addition, bidirectional communication with a lab-
oratory Computer System reduces the work of the
technician in delivering sample and control into the
sample cups and in starting the analyser.
Detection and linearity limits
The detection limit of the assays (mean + 3 SD) was
determined by measuring 30 different drug-free sam-
ples (tab. 3). The immunologieal assays showed a
linear response up to the highest calibrator level, and
this was confirmed by measuring different dilutions
öf samples exhibiting high drug concentrations.
Test results including qualitative determination ex-
ceeding the calibration ränge should be confirmed by
analysing a diluted sample. It is recominended that
dilution be performed with a drug-free sample; most
control materials used in clinical chemistry are suit-
able for this purpose. As shown in table 3 the linearity
limits for ethanol, acetaminophen and salicylates were
4.0 g/l, 200 mg/1 and 1200 mg/1, respectively.
Analytical precision and accuracy
The intra-assay and inter-assay precisions are süm-
marized in table 4.
Intra- and inter-assay precision for ethanol was in the
usual ränge for alcohol dehydrogenase methods
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Tab. 3. Delection and linearity limits of the qualitative and
quantitative methods used.
Analyte
Barbiturates
Benzodiazepines
Tricyclic antidepressants
Acetaminophen
Salicylates
Ethanol
Unit
mg/1
mg/1
mg/1
mg/1
mg/1
g/l
Detection
limit
0.04
0.04
(0)
1.9
32
0.04
Linearity
limit
3.5
0.4
0.3
200
1200
4.0
(CV% < 8%)1)- Variations for acetaminophen and
salicylates were in the ränge usually accepted for drug
monitoring, i.e. less than 10%.
Although barbiturates, benzodiazepines and tricyclic
antidepressants are only determined qualitatively, pre-
') permitted limit of deviation for low levels of ethanol (exlernal
quality control from the Deutsche Gesellschaft für Klinische
Chemie, Bonn, Gennany)
cision data can be given, because primary results are
quantitative and transformed into qualitative results
by setting a decision limit.
A special feature of the EMIT principle is the some-
times higher precision with low rather than high an-
alyte concentrations. Accuracies measured with con-
trol materials are summarized in table 5. Although
the methods used for determination of the target
values were not the same äs the adapted methods, the
deviations lay in an acceptable ränge for screening
determinations.
Correlation with comparison methods
Serum determinations of barbiturates, benzodiaze-
pines and tricyclic antidepressants were compared
with results of the EMIT single test using the decision
limit suggested by the manufacturer and a lowered
decision limit. No negative results (fig. 1) were ob-
Tab. 4. Analytical precision of automated procedures for qualitative and quantitative methods in serum.
Analyte
Barbiturates (mg/1)
Benzodiazepines (mg/1)
Tricyclic antidepressants (mg/1)
Acetaminophen (mg/1)
Salicylates (mg/1)
Ethanol (g/l)
N
10
10
10
10
10
10
10
10
10
10
10
Within-run
Mean
0.80
1.88
0.22
0.27
0.23
0.42
46.5
73.4
157.1
0.65
2.75
SD
0.04
0.13
0.01
0.02
0.009
0.02
6.1
2.67
1.5
0.03
0.034
CV (%)
11
7
5
8
4
5
13
4
1
4.6
1.2
N
19
6
19
6
19
6
8
19
6
20
10
Between-run
Mean
1.09
3.17
0.25
0.30
0.23
0.18
128
71.8
133
0.60
2.03
SD
0.38
0.24
0.01
0.05
0.02
0.02
7.4
3.24
0.8
0.02
0.045
CV (%)
35*
8
4
17
9
11
6
5
1
3
2.2
* concentration near detection limit
Tab. 5. Accuracy of automated procedures for qualitative and quantitative methods in serum.
Analyte
Barbiturates
Benzodiazepines
Tricyclic antidepressants
Acetaminophen
Salicylates
Ethanol
Material
Abbott L
EMIT st
Abbott L
EMIT st
Abbott M
EMIT st
Syva Control
Biorad TDM 3
Biorad TDM 2
Biorad TPM 3
Fluinorm 1
Fluinorm 2
Target value
mg/1
3.0
3.0
0.3
0.3
0.2
0.2
75
135
156
454
0.63
1.52
Result
mg/1
2.9
2.83
0.33
0.32
0.22
0.16
78.9
126
159
490
0.62
1.55
Difference
mg/1
0.1
0.17
0.03
0.02
0.02
0.04
3.9
9
3
36
0.01
0.03
Deviation
%
- 3
- 6
+ 10
+ 7
+ 10
-20
+ 5
- 7
+ 2
+ 8
+ 1
+ 2
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a) Barbituratcs EMIT tox
(RA-1000)
EMIT sl
proposcd cut-off
EMIT st
Jowered cut-off
7
6
0
60
b) Benzodiazepines EMIT tox
(RA-1000)
15
9
0
49
20
4
2
47
EMIT st
proposed cut-off
EMIT st
lowered cut-off
c) Tricyclic antidepressants
EMIT st
proposed cut-off
EMIT st
lowered cut-off
Fig. 1. Discrepancies between determinations using the RA-
1000 analyser and the EMIT st. For EMIT st two
decision limits were used, that proposed by the manu-
facturer (3.0 rag/l secobarbital; 0.3 mg/1 diazepam;
0.2 mg/l nortriptyline) and the detection lirait (sample
blank).
served with the automated method on the RA-1000
in comparison with the single test procedure. The
greater number of positive results is probably due to
the lower detection, e. g. decision limit of the auto-
mated procedure.
Fig. 2. Comparison of results from the present quantitative
analytical procedures with those from other routinely
used methods.
16—42 samples were analysed with the present quanti-
tative procedures and with the comparison methods äs
indicated. Linear regression was calculated by the
method of least squares (15) and by the method of
Bablok ti-dl (16).
EMIT tox
(RA-1000)
3
3
0
46
4
2
0
46
160
140
-
"
20 40 60 80 100 120 UO
Paracetemol (cplorimetric method) [mg/l]
l
160
a. acetaminophen (paracetamol) compared with the
method of Price (13).
linear regression: n = 30; r = 0.946
y = -0.12 + 0.85x
Bablok et al.: y = -3.22 + 0.896x
10 more samples gave results < 10 mg/1 with both
methods.
=;800
>
f 60°
E
•g 500
300-
200-
100-
1 OL-
co 0 100 200 300 400 500 600 700
Salicylate (manual colorimetric method) [mg/l]
800
b. salicylate compared with the manual colorimetric
method.
linear regression: n = 16; r = 0.998
y = -1.5 + 0.998x
Bablok et al.: y = -2.1 + Ix
10 more samples gave results < 50 mg/1 with both
methods.
4.5
4.0
3.5
S 3.0
0.5
3.5 4.0 4.50.5 1.0 1.5 2JO 2.5 3.0
Ethanol (GC) [g/l]
c. ethanol compared with headspace gas chromato-
graphy.
linear regression: n = 42; r = 0.993
y = 0.09 + 0.97x
Bablok et al.: y = 0.06 -f 0.98x
16 more samples gave results < 0.15 g/l with both
methods.
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The EMIT method for acetaminophen, which was
adapted to the RA-1000 analyser, was compared with
the manual colorimetric method of Price (13). The
correlation coefficient was 0.946 (fig. 2a). From figure
2a deviations up to 50% from the regression line for
low concentrations can be seen. However, both meth-
ods fulfil the clinical requirements for detection and
quantification of acetaminophen overdosage.
Figure 2b compares the results for the analysis of
salicylates in serum, using the present method and a
manual procedure with the same test kit.
The ethanol determinations on the RA-1000/RAXT
were compared with the candidate reference method
(headspace gas chromatography). The results in figure
2c exhibited a good correlation (r = 0.993). Only a
very small intercept due to the more extended detec-
tion limit of gas chromatography was detected.
Stability of working reagents and calibration
curves
Reconstituted reagents for EMIT methods and sali-
cylates exhibited Stability for at least 6 weeks at
4—8 °C. In routine use over three years, the Stability
of prediluted working reagents at 4—8 °C was gen-
erally at least 14 days, äs seen from a typical Stability
curve of controls measured daily without any recali-
bration (fig. 3).
The validity of calibration curves, when using working
reagents from the same test kit, was checked by meas-
uring accuracy controls. The maximal deviation al-
lowed for keeping the old calibration curve was 30%
for the qualitative procedures. It was usually unnec-
essary to perform a new calibration, when working
Solutions were prepared from the same reagent bottle.
Ethanol reagents were freshly prepared every two
days, because of their limited Stability.
The Stability of serum „samples using Vacutainer®
tubes has been reported by others (20).
Analytical sensitivity and setting of the de-
cision limits
The detection limits (sample blank) of the qualitative
assays were found to be very low (tab. 3). The zero
calibratpr exhibited a higher äbsorption signal than
nearly all the drug-free samples that were tested. This
indicated a matrix difference between calibrators and
freshly sampled serum of plasma, resulting in an
obviously very low matrix dependence. To avoid pos-
sibly positive results from drug traces we decided to
set the decision limits to the first calibrator concen-
tration above zero.
50
40
30
20
S 10
-20
-30
-40
-50 8 10
Day
12 U 16 18
8 10
Day
12 16 18
Fig. 3. Stability of reagents and calibration curves. Samples of
a precision control material were analysed once a day
over a period of 17 days without any recalibration.
Values are given äs deviation (%) from the measurement
at the first day.
Reagents were stored at 4—8 °C. First values were: 105
mg/1 salicylate (O); 1.60 mg/1 barbiturates ( ); 0.11
mg/1 benzqdiazepines (o); 7.3 mg/1 paracetamol (A);
0.27 mg/1 tricyclic antidepressants(-h).
a. quantitative assays
b. qualitative assays
These decision limits were:
barbiturates: 0.5 mg/1 (decision calibrator:
secobarbital)
benzodiazepines: 0.05 mg/1 (decision calibrator:
nordiazepam)
tricyclic 0.07 mg/1 (decision calibrator:
antidepressants: nortriptyline)
Testing the analytical sensitivity for the determination
of tricyclic antidepressants with the method intro-
duced by Kutter (17), using a decision calibrator of
0.07 mg/1 nortriptyline, resulted in NJO = 0.05 mg/1
and N90 = 0.1 mg/1 (fig. 4).
Lowering the decision limits produced a distinct in-
crease of analytical sensitivity (tab. 6) compared with
decision limits proposed by the manufacturer.
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30
ü=
§25
l201
0>
|15
(0
|io
'Si 5
0 1 %
|i
0.025 0.050 0.075 0.100
Nortriptyline [mg/l]
Tab. 6. Effect of lowered decision limits.
Fig. 4. Analytical sensitivity of the determination of tricyclic
antidepressants.
According to Kutter (17), 30 different drug-free samples
were spiked with increasing amount of nortriptyline and
the concentrations measured were compared with the
chosen decision limit (0.07 mg/1).
The decision values for the analgesics, paracetamol
and salicylates, were set near to the upper therapeutic
ränge limit (21):
acetaminophen: 10 mg/1
salicylates: 50 mg/1
/
Ethanol values less than 0.15 g/l were not given quan-
titatively, in accordance with the recommendations of
an expert group (22).
Use of the new analytical programme äs a
screening procedure
In order to demonstrate the diagnostic Utility of the
present programme, the results of its use oVer a 6
month period in our laboratory are summarized in
table 7.
When analysed with the present analytical pro-
gramme, 139 out of 188 serum samples (74%) gave
at least one positive result. As can be seen, benzodi-
azepines (40%) and ethanol (36%) were most fre-
quently positive. The distribution of values obserVed
is given in figure 5. Out of 188 samples, 28 (15%)
were positive for benzodiazepines in combination with
ethanol. However, other combinations were detected
äs well.
Only in 70 of these 188 cases (37%) were further
determinations requested. Of these, 23 (33%) showed
no evidence of intoxication in a more extended screen-
ing procedure, using various urine tests (12). Of the
remaining 47 patients 15 gave a positive result for
Barbitu- Benzodia- Tricyclic anti-
rates zepines depressants
Proposed decision
limit (mg/1)
Positive results
Negative results
Lowered decision
limit (mg/1)
Positive results
Negative results
3.0
7
69
0.6
15
61
0.3
• r
13
63
0.05
23
53
0.2
3
52
0.07
6
49
Tab. 7. Application of the analytical programme to patients,
where intoxication was suspected from anamiiesis or
clinieal examination.
a) Total results (with use of the lowered decision· limits)
n = 188
Barbiturates
Benzodiazepines
Tricyclic antidepressants
Paracetamol
Salicylates
Ethanol
Positive
25
81
27
6
8
68
Negative
163
107
161
182
180
120
b) Combinations with positive benzodiazepines
n = 81
Barbiturates
Tricyclic antidepressants
Paracetamol
Salicylates
Ethanol
15
13
3
5
28
c) Combinations with positive ethanol
n = 68 ..
Barbiturates
Benzodiazepines
Tricyclic antidepressants
Paracetainol
Salicylates
6
28
10
3
2
opiates in urine. A wide spectrum of other substances
was detected with unspecific colour reactions, e. g. the
tetrabromophenolphthaleinethylester reaction (23)
and the Forrest reaction (3), therapeutic drug moni-
toring, thin layer chromatography and other immu-
noassays in urine. For clinieal purposes, it was nec-
essary to send samples from only 5 patients to external
laboratories for corifirmation and identification of the
drugs involved.
Discussion
General toxicological screening reqüires many ana-
lytical tools, e. g. colour tests (24), immunoassays (25),
thin-layer chromatography (26, 27), gas chromato-
graphy (28-30), high^perfonpance liquid chromato-
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; 5. Distribution of positive results measured in a total of
188 samples. The lowest concentration value given was
used äs the decision limit. The cut-off proposed by the
manüfacturer is marked by an asterisk.
a. barbiturate assay
b. benzodiazepine assay
c. tricyclic antidepressants assay
graphy (31, 32) and/or gas chromatpgraphy/mass-
spectrometry (33, 34). In clioical toxicology, however,
information obtained quickly with simple sereening
tests is very valuable (35—37). On the other band,
haematological, haemostaseological and clinical
chemistry parameters are additionally usefui in acute
poisoning (36, 38). This prompted us to adapt assays
for frequent toxicologically relevant compounds to an
mechanized analyser, which is routinely used for emer-
gency clinical chemistry. The resulting advantages of
this strategy are: no additional technical or personnel
requirements, no time-consuming procedures (for ex-
ample extraction), and high analytical precisibn and
accuracy with a remarkable decrease of reagent costs.
Decision limits
A major aim of toxicological forefield analyses is to
exclude intoxication. Cut-off values of qualitative
sereening tests should be lowered for this purpose äs
far äs possible to avoid false negative fmdings, espe-
cially with substances exhibiting low cross-reactivity.
As a consequence, however, these cut-off values are
in the therapeutic ränge for several drugs. The qual-
itative EMIT tests presented here do not discriminate
between acute intoxications and results due to ther-
apeutic drug application. The applicability of the
sereening programme is, however, not restricted by
this fact, if the main aim of forefield toxicological
analysis is exclusion of intoxication with a high degree
of certainty.
False positive findings, on the other hand, can be
corrected by the results of more specific tests. Two
cut-off limits (for example the lower decision limit
and that proposed by the producer) may be used to
separate "clinically precarious positive" from positive
results. However, this procedure does not eliminate
the problems resulting from differences in cross-reac-
tivity. According to a common agreement (39), each
positive result implying therapeutic or other conse-
quences should be confirmed by a separate test pro-
cedure.
Very low detection limits were estimated from meas-
urements of thirty different drug-free serum samples
for the EMIT serum tests. The obviously very small
matrix dependence of these procedures, however, was
not observed when the tests were calibrated with
aqueous Standards (data not shown).
In view of matrix dependency, the accuracy of the
test procedures should be demonstrated with various
control materials. These are quantitative tests, al-
though they are only qualitatively interpreted. A qual-
ity assurance programme äs used for quantitative
measurements was therefore installed.
The decision limits for the quantitative analgesic de-
terminations (paracetamol and salicylates) were set to
the upper therapeutic ränge, in accordance with the
common use of these drugs and the relatively great
imprecision of the quantitative methods in the lower
concentration ränge.
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Appl ica t ion of the present programme äs a
screening procedure
The relative frequency of positive results with the
different tests detected by our methodology was sim-
ilar to the distribution of results found by Gibitz (36).
These distributions are typical for non-specialized
hospitals where intoxications of patients examined are
usually not severe. Even in these cases, however, tox-
icological analysis is necessary for differential diag-
nostic purposes. Depending on the cut-off values used
äs the decision point for a positive resült, the numbers
of positives may vary by a factor of 2. As can be
deduced from the distribution of positive results äs a
function of present concentration ranges (fig. 5), the
setting of cut-off values äs proposed by the producer
seems not to be optimal, since nearly equal numbers
of samples exhibited values that were higher and lower
than these cut-off values in all three group tests. The
setting of the decision limit near the detection limit
(sample blank) therefore seems to be more reliable.
When the detection limit (sample blank) was used äs
the decision limit, the positive and negative results
agreed well with those found in the single test pro-
cedures. Also, for example, low positive Signals in the
test for tricyclic antidepressants may be due to di-
phenhydramine cross-reativity, e. g. unspecific reactiv-
ity, but this is desirable for forefield toxicology. To
increase the number of intoxications detectable by the
present programme it seems advisable to add further
tests like an immunoassay for opiates (in urine), the
tetrabromophenolphthaleinethylester reaction for the
detection of basic compounds (23) and the Forrest
reactions for the detection of phenothiazines (3).
Future aspects and conclusions
With respect to the necessity of automation in the
modern emergency labofatory, we adapted toxicolog-
ically relevant test procedures for frequeiit drugs to
the RA-1000/RAXT analyser. This programme might
be extended in future by the· inclusion of other im-
munoassays for more substances and/or groups, like
diphenhydramin, antiarrhythmic and antihypertonic
drugs. In our opinion the complete strategy for exclu-
sion of intoxication will comprise the present fully
automated programme, probably with some addi-
tions, and unspecific colour reactions. Positive results
should then be further investigated and, if necessary,
differentiated with more powerful technology such äs
gas chromatography/mass spectrometry.
In conclusion, the present serum screening pro-
gramme proved to be a suitable first step in testing
patients entering a non-specialized hospital, detecting
75% of total "positive" patients (11). The fully mech-
anized serum tests can be inclüded in the programme
of emergency laboratories, and they can be performed
by the technician within 15 minutes with little addition
to the workload. In addition the low reagent con-
sumption keeps the reagent costs within an acceptable
ränge.
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